Lifeward Q1 revenue $5.0M (-6% YoY); net loss narrows to $0.46/sh; reaffirms FY25 guidance $28-30M

Lifeward Ltd.

2025-Q1 EPS reported -$0.46 revenue$5,034,000

Revenue $5.0M, down from $5.3M YoY; AlterG up 17% to $3.3M offset by ReWalk/restore drop.
GAAP gross margin improved to 42.2% from 26.4%; adjusted operating loss $4.6M vs $5.5M.
Net loss $4.8M ($0.46/sh) vs $6.3M ($0.73/sh); cash $5.7M, no debt; raised $0.5M ATM.
Launched ReWalk 7 after FDA clearance; first commercial insurance claim approved.
Partnership with CorLife (NuMotion) for workers' comp; BARMER deal adds 8.5M covered lives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.